Infectious Diseases – Products

PacBio (NASDAQ: PACB), announced a significant publication from Radboud University Medical Center (Radboudumc) and its research partners in the American Journal of Human Genetics.

This application note explores how an innovative panel provides a comprehensive tool for infectious disease research and public health monitoring.

This application note explores how this advanced technology is a powerful tool for public health monitoring and viral discovery research.

Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs).

ACROBiosystems offers premium antigens (pre-fusion F, post-fusion F, glycoprotein G) and a Monoclonal Anti-Nipah Antibody for accurate ELISA-based evaluation and vaccine potency studies, supporting Nipah and Hendra virus research.

Cytokines are central to understanding autoimmune diseases and advancing treatments. Targeted therapies improve patient outcomes and quality of life. To support drug development, we have designed recombinant cytokines and receptor proteins.

Unlock actionable insights with i-Ome™ Discovery, an advanced platform for biomarker research. With precision and reliability, uncover targetable biomarkers: disease-associated proteins, pathogenic antibodies, and protective antibodies.

Oxford Nanopore, announced a landmark strategic partnership with the UK Government. This partnership brings together the UK’s world-class scientific organisations Genomics England, UK Biobank and NHS England, alongside Oxford Nanopore.

Grant supports the expansion of their rapid, high-resolution LinkPrep™ technology in transforming cancer research.

Zymo Research, Unravel Biosciences, and Channel Islands Marine & Wildlife Institute team up to combat increasing cases of domoic acid poisoning in sea lions.